FDAnews
www.fdanews.com/articles/187612-french-company-receives-ce-mark-for-laparoscopic-applicator

French Company Receives CE Mark for Laparoscopic Applicator

July 13, 2018

Surgical hemostasis specialist Biom’Up received the CE Mark for its laparoscopic applicator, extending its indication.

The extended indication allows surgeons to use HemoBlast Bellows hemostatic powder for both open and laparoscopic surgery.

The device’s additional indication allows the device to be used for hemostasis when controlling bleeding in classical procedures is impractical, ineffective or impossible during laparoscopic procedures for vascular, abdominal, urology, gynecology, neck and head surgery.

View today's stories